共 193 条
[1]
Wong WL(2014)Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis Lancet Glob Health 2 e106-e116
[2]
Su X(2017)Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis Lancet Glob Health 5 e1221-e1234
[3]
Li X(2013)Clinical classification of age-related macular degeneration Ophthalmology 120 844-851
[4]
Flaxman SR(2016)Current therapeutic developments in atrophic age-related macular degeneration Br J Ophthalmol 100 122-127
[5]
Bourne RRA(2014)Anti-vascular endothelial growth factor for neovascular age-related macular degeneration Cochrane Database Syst Rev 8 005139-5
[6]
Resnikoff S(2014)Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering J Ophthalmol 2014 510285-168
[7]
Ferris FL(2011)Pharmacological treatment of dry age-related macular degeneration (AMD) Taiwan J Ophthalmol 1 2-1436
[8]
Wilkinson CP(2017)Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration Cochrane Database Syst Rev 22 1-997
[9]
Bird A(2017)Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration Cochrane Database Syst Rev 119 1417-100
[10]
Hanus J(2018)Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review Health Technol Assess 120 997-2015